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In man, gene products of the major histocompatibility complex (MHC) are involved 
in the T-cell-mediated cytotoxicity directed to minor histoeompatibility antigens.  In 
a  previous  publication,  we demonstrated  that  self HLA antigens  were required  to 
obtain cell-mediated cytotoxicity directed to the male-associated antigen, H-Y. (1, 2). 
Analogous  restriction  phenomena  in  man  have also  been  shown  for virus-infected 
target cells and for DNCB-modified target cells (3, 4). 
To explain the restriction phenomenon, two hypotheses have been put forward (5). 
According to one hypothesis (altered self) the antigens recognized can be regarded as 
neoantigens created by molecular interactions between self compatible HLA-A, -B, or 
-C  gene  product  and  the  foreign  antigen.  This  altered  self concept  is  a  logical 
consequence  of classical theories of immunology such  as the clonal selection  theory 
(6,  7),  and  this  interpretation  is  favored by some investigators  (8,  9).  According to 
another hypothesis (dual recognition)  the antigens are seen by cells which have two 
receptors; one recognizes self compatible HLA-A, -B, or -C, and the other recognizes 
the foreign antigen.  This concept is supported  by other authors  (10-13)  but  at  the 
present  moment  a  firm  choice  cannot  be  made  between  these  two  hypotheses. 
Whichever is true, two aspects of the specificity of T-cell recognition in cell-mediated 
lympholysis  (CML)  are  important  to  evaluate.  First,  is  the  anti-self or altered-self 
reaction clonal implying the existence of multiple populations of specific immune cells 
(14,  15)?  Second,  is the anti-self or altered-self reaction attributable  to lymphocytes 
with polyvalent speeificities as suggested by others  (16)?  The discovery of a  case of 
HLA-restricted CML reactivity directed to the H-Y antigen in which the killing was 
restricted by a  requirement either for self HLA-A2 or B7, and the development of a 
monolayer absorption technique by one of us (15), gave us the opportunity to answer 
these questions. 
Materials and Methods 
Lymphocytes of two female patients (patients A and B) were used. The HLA-restricted H-Y 
killing  phenomenon  as  described  in  previous studies  was  demonstrated  in  both  (2,  17). In 
reference  17, patient  1 is equivalent to patient A and patient B is the individual referred to as 
the third patient. Patients A and B were both suffering from aplastic anemia and had received 
multiple transfusions,  a situation which severely limited our access to materials. Lymphocytes 
from A and B were cultured for 6 d with lymphoeytes from HLA-A, -B, and -C identical,  but 
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HLA-D different male individuals.  After this in vitro sensitization,  specific anti-HLA-A2-H-Y 
cytotoxic cells were generated in the case of patient A (17). Patient B formed cytotoxic cells 
which specifically  recognized  HLA-A2 male target cells and HLA-B7 male target cells (Table 
II). We demonstrated, that the effector cells of the patients studied retained their specificities 
for HLA-A2 males for a  long period of time and that by recalling immunological memory 
(using lymphocytes from HLA-D different  unrelated male donors)  it was possible to reinduce 
high levels of specific killing  (17). After culturing, the sensitized  effector cells were overlaid on 
monolayers, according to the techniques described  elsewhere  (15), which were based on the 
mouse system introduced by Brondz et al. (16). The nonadherent cells were removed and tested 
on a panel of target cells, which had been incubated with phytohemagglutinin for 3 d and then 
labeled with sodium Slchromate. Cytotoxicity as exemplified in Tables I and III, was measured 
and calculated as a percentage according to the methods described  elsewhere (17). 
Preparation of the Monolayer.  Monolayers were made of fresh peripheral blood lymphocytes 
adhered to Petri dishes treated with poly-L-lysine; the nonadherent cells were removed after 1 
h at room temperature. The effector cells were overlaid and incubated for 1 h at 37°C  and 
nonadherent cells were removed and tested (reference  15). The calculation of the depletion of 
cytotoxicity, referred to in the text, was calculated as a percentage of the unabsorbed population. 
Results 
After 6 d of in vitr  O sensitization, the responder cells of patient A reacted specifically 
against  HLA-A2  males,  as  illustrated  in  Table  I  and  in  reference  1.  These  were 
absorbed on four different monolayers, which were numbered one to four and were, 
respectively, HLA-A2  male, non-HLA-A2  male,  HLA-A2  female,  non-HLA-A2  fe- 
male. The nonadherent cells were removed and tested on a panel of unrelated target 
cells, in which the same specificities were represented. 
Effector cells  absorbed  on  monolayer  1  (HLA-A2  male)  gave strongly  reduced 
cytotoxic activity directed  to  all  HLA-A2 male-positive target  cells.  The depletion 
varied from 47 to 64%. Absorption on monolayer 2 (non-HLA-A2 male), 3 (HLA-A2 
female),  and  4  (non-HLA-A2  female)  showed  no  significant  reduction  in  cytolysis 
(Table I). These results illustrated that only the appropriate monolayer, i.e. an HLA- 
A2 male monolayer, could absorb the specific killer cells. 
Patient  B  lymphocytes showed cytotoxic activity against two independent  pheno- 
types namely, HLA-A2 and HLA-B7 male target cells  (Table II). Using these cells, 
we investigated whether it was possible to specifically absorb one clone of cytotoxic 
cells  and  leave the  other  intact,  thus  demonstrating  the  clonal  expression of these 
specific killer cells. Table III showed that when effector cells recovered from monolayer 
1  (HLA-A2 male) were tested on the panel of target cells, almost complete removal of 
the cytotoxic activity could be demonstrated against male HLA-A2 target cells (target 
5-8).  The  converse effect was  found  after absorption  with  monolayer  3  (HLA-B7 
male)  and,  in  this  case,  the  reaction  directed  to  HLA-B7  males  was  specifically 
depleted. Double absorption further depleted the killer cell clones, but because of the 
limited amount of material available, it was not possible to perform this in all cases 
(E.  Goulmy,  unpublished  results).  The  most  effective  reduction  (up  to  82%)  in 
cytotoxicity was obtained with  monolayer 4  (HLA-A2 and  HLA-B7 male).  Killing 
activity  directed  to  the  target  cells  which  carried  both  restricting  HLA  antigens 
(HLA-A2 and HLA-B7), was only partially reduced  after absorption with an HLA- 
A2 male monolayer (monolayer 1), or HLA-B7 male monolayer (monolayer 3). These 
results provide strong evidence that the anti-B7 clone could be absorbed independently 
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TABLE  I 
Absorption of the Anti-H-Y,"  HLA-A2 Cytotoxicity 
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Target  HLA-A2  Sex  0* 
cell 
Monolayers 
1  2  3  4 
A2 ~  NonA2 C~  A2 t~  Non A2 
1  +  d  61  ±  1.4  26  ::1:3.1  61  3=  1.6  54  ±  3.7  57  3=  3.9 
2  +  d  82  3=  1.5  29  3=  1.1  80  3=  0.9  67  +  2.6  77  .4-  1.2 
3  +  t3  70  3=  1.3  26  3=  1.2  71  ±  1.8  65  ±  1.7  69 ±  0.4 
4  +  ~  66  ±  0.7  35  ±  3.4  73  ±  1.2  67  ±  3.9  72  ±  3.5 
5  -  c~  -9  ±  4.9  -7  ±  9.3  -5  ±  2.6  -6  ±  9.2  -4  ±  3.5 
6  -  ~  -10  ±  0.7  -7  +  3.1  -5  3=  1.1  -7  ±  2.8  -4  3=  2.2 
7  -  c~  -10  3=  6.6  -8  3=  4.5  -6  3=  3.8  -8  3=  5.5  -5  ±  1.6 
8  +  ~  -8  +  4.6  -10  3=  3.5  -4  ±  3.8  -9  3=  3.1  -2  +  4.3 
9  +  ~  -6  3=  5.3  -9  +  0.7  -3  3=  3.0  -9  ±  4.9  -2  3=  5.3 
l0  +  ~  -1  ±  3.7  --4  3=  5.1  0  +  8.4  -2  3=  4.4  +  1 ±  3.3 
ll  +  ~  -6  +  2.0  -2  3=  7.7  -6  3=  3.8  --8  ±  1.9  -4  3=  4.0 
12  -  ~  -4  ±  9.1  -3  3=  3.7  0  3=  4.5  -2  3=  2.2  -1  +  5.5 
13  -  9  -6  3=  3.2  -8  +  3.6  -6  ±  2.4  -6  +  1.8  -4  3=  6.1 
14  -  ~  -7  +  3.2  -7  3=  4.4  -3  3=  3.5  -6  3=  3.5  -3  ±  3.0 
Sensitized cells of patient A  before and after absorption on different monolayers, tested on a  panel of 
target cells (1-14).  Phenotype of patient A: ~, HLA-A2, -;  B12, w40; Cw3, -.  Effector: target ratio = 
50:1. Different ratios were tested (Not shown). The experiments were repeated at least once. ~, percent 
lysis =t:  variation coefficient. 
* Without absorption. Monolayers:  1.  HLA-A2 male. 2.  Non HLA-A2 male. 3.  HLA-A2 female. 4.  Non 
HLA-A2 female. 
TABLE  II 
HLA-A2 and HLA-B7 Restricted H- Y Killing Shown by Patient B*, Phenotype: HLA-A2, 28; B7,  15; 
Cw3, - 
CML 
Serological type of target 
HLA-A2 
÷ 
15  0 
CML 
8  11 
HLA-B7 
+ 
+  II 
-  3 
0 
II 
CML 
+ 
HLA-A2 
g 
I'5 
0 
Sex of the target 
o 
0 
HLA-B7 
d 
+  II 
CML 
-  0 
* Patient B was sensitized in vitro with lymphocytes of an HLA-A, -B, and -C identical, HLA-D different, 
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TABL~  III 
Independent Absorption of the Anti-HLA-A2; H- Y and Anti-HLA-B7; H- Y Cytotoxicity 
Target  HLA-A2/-  Sex  O* 
cell  HLA-B7 
Monolayers 
2 
1  3  4 
A2 d'  Non A2 & B7  B7 ~  A2, B7 
Patient  +/+  9  0  ±  3.1  -1  ±  4.9  +  1  ±  3.0  0  ±  4.2  -3  ±  1.1 
1  +/+  d~  89  ±  3.8  63  ±  3.2  85  ±  5.6  54 ±  4.6  38 ±  3.0 
2  +/+  d  84  ±  2.8  51  ±  2.8  78  ±  3.5  42 ±  3.3  24 ±  2.5 
3  +/+  d  87  ±  2.0  61  ±  3.5  81  ±  1.4  48  ±  3.7  28  ±  2.2 
4  +/+  d  60  ±  4.3  43  ±  4.7  52  ±  3.1  27  ±  1.1  15  ±  3.6 
5  +/-  d  47  ±  1.1  9 ±  2.9  43  ±  3.5  33  ±  3.5  16 ±  3.0 
6  +/-  d  47  ±  2.2  8 ±  4.8  41  ±  1.3  31  ±  3.7  12 ±  1.1 
7  +/-  d  47  ±  4.0  14 ±  4.1  43  ±  3.1  32 ±  2.1  14 ±  2.4 
8  +/-  d  57  ±  2.4  13 ±  3.9  44 ±  2.0  34 ±  1.6  16 ±  2.7 
9  -/+  ¢~  65 ±  3.9  47  +  2.4  61  ±  1.3  25  ±  3.4  14 ±  2.4 
10  -/+  d  82  ±  3.5  64 ±  4.4  78  ±  2.6  32  ±  3.2  27  ±  0.7 
11  -/+  d  73  ±  0.6  52  ±  3.4  62 ±  2.7  24  ±  3.0  13 ±  0.8 
12  -/-  d  7 ±  1.5  0 ±  5.3  2 ±  2.1  3 ±  5.4  1 ±  5.2 
13  -/-  d  9 ±  3.5  4 ±  5.1  8 ±  5.0  0 ±  0.8  2 ±  2.1 
14  -/-  t3  2  ±  6.1  0  ±  4.0  1  ±  2.6  -1  ±  6.8  -2  ±  2.2 
Sensitized  cells of patient  B before and after absorption on different monolayers,  tested on a panel of 
target cells  (1-14).  Phenotype of patient B: 9, HLA-A2, 28; B7,  15; Cw3, -. Effector:  target ratio 50:1. 
Different ratios were tested (not  shown).  The experiments were repeated at least once. ~', percent lysis 
±  variation coefficient. 
* Without absorption.  Monolayers:  1.  HLA-A2 male.  2.  Non HLA-A2, Non HLA-B7 male.  3.  HLA-B7 
male. 4. HLA°A2, HLA-B7 male. 
Discussion 
The reduction obtained in the level ofcytotoxicity in these experiments was thought 
to  be  attributable  to  removal  of  specific  subpopulations  of  effector  cells  by  the 
monolayer and not by admixed soluble antigen or cells detached  from the monolayer. 
Experiments  in  mouse using a  similar system  demonstrated  that  cells detached  from 
the monolayer were incapable of cold target  inhibition  (18).  These observations were 
confirmed in the human  monolayer absorption  techniques used here  (15). 
We  cannot  draw  conclusions  from  these  data  which  favor  altered  self or  dual 
recognition.  In  the  former  case,  the  clonal  expression  of  killing  would  fulfill  the 
prediction of the clonal selection theory and  altered self would simply be regarded  as 
an  alloantigen.  In the latter case,  the clonal expression  of anti-self would imply that 
allelic  exclusion  existed  with  regard  to  anti-self  HLA  receptors,  i.e.  T-cell  clones 
specialize in different  HLA-A,  -B, and  -C gene products  of the self type and  are thus 
clonally  expressed.  Furthermore,  the  avidity  of the  two  receptors  (self and  foreign) 
would be interdependent. 
Our  findings  are  in  agreement  with  those  of others  who  observed  that  cytotoxic 
effector cells directed  to virus-infected syngeneic cells could be blocked  in cold target 
inhibition  experiments  only  by  the  virus-infected  syngeneic  cells  and  not  by  virus- 
infected allogeneic cells. Thus, self and foreign determinants  are required on the same 
cell to obtain blocking  (19).  This general rule is confirmed here and  extended  by our 
experiments  because  they suggest  that  in  man  this  anti-self or altered-self activity is 
clonally  expressed.  The  advantage  of the  absorption  technique  as  used  here  is  that GOULMY ET AL.  BRIEF  DEFINITIVE REPORT  549 
clones  can  be  physically  removed  from  cell  suspensions,  thus  giving  evidence  for 
separate populations. In contrast, cold target inhibition studies result only in blocking 
of receptors and theoretically cannot distinguish between polyvalent and monovalent 
effector  cells.  Of  great  interest  was  the  observation  that  a  small  but  significant 
reduction in lysis of B7 positive cells occurred after absorption on A2 monolayers and 
similarly, a  reduction  occurred in the killing of A2-positive cells after absorption on 
B7 monolayers. There was no clear explanation of this phenomenon but the possibility 
existed that it was attributable to clones of killer cells which recognized antigens that 
were shared by both A2 and B7 bearing molecules (20,  21).  No reduction  at all has 
been found using nonrelevant male or female monolayers. 
The possible relevance of these findings to the mechanisms involved in the initiation 
of autoimmune disease in man has been discussed elsewhere (22). 
Summary 
A monolayer absorption technique was used to test the hypothesis that killer cells 
directed to self HLA-associated minor histocompatibility antigens (H-Y) were divisible 
into  subsets.  The  results  showed  that  sensitized  killer  cells,  which  recognized  two 
combined antigens  HLA-A2;  H-Y and HLA-B7; H-Y could indeed be divided into 
two populations. One was directed to HLA-A2; H-Y and the other to HLA-B7; H-Y. 
These results can be interpreted in the context of the altered self hypothesis. However, 
when  interpreted  in  the  context  of the  dual  recognition  hypothesis,  they  strongly 
suggest  that  independant  clones  of killer T  cells exist which  are committed to the 
recognition of self HLA. 
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